2XR-62581-77307
4 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 303 / GA
- Registered
- 2022-07-11
- Relationship
- Adult relative or friend
- Guardian
- ZC5-27777-92000
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-20
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Dose 2 — Pfizer-BioNTech
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2022-07-11
Registered in v-safe
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-23
- 2022-10-09
-
2022-10-14
Survey response — day 28, dose 4, dependentMedDRA: Nasopharyngitis — Feeling: GoodFree text: Has a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-23
- 2022-12-18
- 2023-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | No |
| 2 | 2021-04-10 | Pfizer-BioNTech | No |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 28, dose 4, dependent
Symptoms: Has a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release